10/18/2024

Janusmed sex and gender

Janusmed sex and gender – azathioprine

Janusmed Sex and Gender is a knowledge database providing information on sex and gender aspects of drug treatment. The knowledge database is primarily intended to be used by physicians and healthcare professionals. The texts are general and should not be considered as treatment guidelines. The individual patient’s physician is responsible for the patient’s drug treatment.

Back to index
C C
C C

Azathioprine

Azathioprine

Class : C

Show all info

Print

Contact us

  1. Nguyen TV, Vu DH, Nguyen TM, Lachaux A, Boulieu R. Relationship between azathioprine dosage and thiopurine metabolites in pediatric IBD patients: identification of covariables using multilevel analysis. Ther Drug Monit. 2013;35:251-7.

  2. Wu J, Gao Y, Yang C, Yang X, Li X, Xiao S. Low-dose azathioprine is effective in maintaining remission among Chinese patients with Crohn's disease. J Transl Med. 2013;11:235.

  3. Bouhnik Y, Lémann M, Mary JY, Scemama G, Taï R, Matuchansky C et al. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet. 1996;347:215-9.

  4. Fraser AG, Orchard TR, Jewell DP. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review. Gut. 2002;50:485-9.

  5. Hon KL, Ching GK, Leung TF, Chow CM, Lee KK, Ng PC. Efficacy and tolerability at 3 and 6 months following use of azathioprine for recalcitrant atopic dermatitis in children and young adults. J Dermatolog Treat. 2009;20:141-5.

  6. Mertin J, Knight SC, Rudge P, Thompson EJ, Healy MJ. Double-blind, controlled trial of immunosuppression in treatment of multiple sclerosis. Lancet. 1980;2:949-51.

  7. Statistikdatabas för läkemedel. Stockholm: Socialstyrelsen. 2022 [cited 2023-03-02.]

  1. Nguyen TV, Vu DH, Nguyen TM, Lachaux A, Boulieu R. Relationship between azathioprine dosage and thiopurine metabolites in pediatric IBD patients: identification of covariables using multilevel analysis. Ther Drug Monit. 2013;35:251-7.
  2. Wu J, Gao Y, Yang C, Yang X, Li X, Xiao S. Low-dose azathioprine is effective in maintaining remission among Chinese patients with Crohn's disease. J Transl Med. 2013;11:235.
  3. Bouhnik Y, Lémann M, Mary JY, Scemama G, Taï R, Matuchansky C et al. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet. 1996;347:215-9.
  4. Fraser AG, Orchard TR, Jewell DP. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review. Gut. 2002;50:485-9.
  5. Hon KL, Ching GK, Leung TF, Chow CM, Lee KK, Ng PC. Efficacy and tolerability at 3 and 6 months following use of azathioprine for recalcitrant atopic dermatitis in children and young adults. J Dermatolog Treat. 2009;20:141-5.
  6. Mertin J, Knight SC, Rudge P, Thompson EJ, Healy MJ. Double-blind, controlled trial of immunosuppression in treatment of multiple sclerosis. Lancet. 1980;2:949-51.
  7. Statistikdatabas för läkemedel. Stockholm: Socialstyrelsen. 2022 [cited 2023-03-02.]